These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18981161)

  • 1. Breaking of CD8+ T cell tolerance through in vivo ligation of CD40 results in inhibition of chronic graft-versus-host disease and complete donor cell engraftment.
    Kim J; Park K; Kim HJ; Kim J; Kim HA; Jung D; Kim HJ; Choi HJ; Choi SY; Seo KW; Cho HR; Kwon B
    J Immunol; 2008 Nov; 181(10):7380-9. PubMed ID: 18981161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of alloantigen-specific CD8+ T cell anergy to CD8+ T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor.
    Kim J; Choi WS; Kang H; Kim HJ; Suh JH; Sakaguchi S; Kwon B
    J Immunol; 2006 May; 176(9):5223-31. PubMed ID: 16621987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus.
    Puliaev R; Puliaeva I; Welniak LA; Ryan AE; Haas M; Murphy WJ; Via CS
    J Immunol; 2008 Jul; 181(1):47-61. PubMed ID: 18566369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of CD8+ T-cell anergy by CD4+CD25+ regulatory T cells in chronic graft-versus-host disease.
    Kim J; Kim HJ; Choi WS; Nam SH; Cho HR; Kwon B
    Exp Mol Med; 2006 Oct; 38(5):494-501. PubMed ID: 17079865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
    Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
    J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-18 prevents the development of chronic graft-versus-host disease in mice.
    Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
    J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice.
    Foster AD; Soloviova K; Puliaeva I; Puliaiev M; Puliaev R; Finkelman F; Via CS
    J Immunol; 2011 Jun; 186(11):6238-54. PubMed ID: 21531893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H; Kurtz J; Shaffer J; Sykes M
    J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases.
    Nozawa K; Ohata J; Sakurai J; Hashimoto H; Miyajima H; Yagita H; Okumura K; Azuma M
    J Immunol; 2001 Nov; 167(9):4981-6. PubMed ID: 11673505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
    Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
    J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.
    Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D
    J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. During acute graft versus host disease CD28 deletion in donor CD8
    Uri A; Lühder F; Kerkau T; Beyersdorf N
    Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody.
    Taylor PA; Panoskaltsis-Mortari A; Noelle RJ; Blazar BR
    J Immunol; 2000 Jan; 164(2):612-22. PubMed ID: 10623802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The host environment regulates the function of CD8+ graft-versus-host-reactive effector cells.
    Chakraverty R; Flutter B; Fallah-Arani F; Eom HS; Means T; Andreola G; Schwarte S; Buchli J; Cotter P; Zhao G; Sykes M
    J Immunol; 2008 Nov; 181(10):6820-8. PubMed ID: 18981100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.